Advertisement

Topics

Johnson & Johnson And Bayer Agree To $775M Settlement Over Accusations They Didn’t Warn About Blood Thinner Side Effects

08:26 EDT 26 Mar 2019 | Kaiser Health News

The agreement that stemmed from patients who used the popular blood thinner Xarelto caps one of the more high-profile instances of product liability litigation facing the pharmaceutical industry in recent years.

Original Article: Johnson & Johnson And Bayer Agree To $775M Settlement Over Accusations They Didn’t Warn About Blood Thinner Side Effects

NEXT ARTICLE

More From BioPortfolio on "Johnson & Johnson And Bayer Agree To $775M Settlement Over Accusations They Didn’t Warn About Blood Thinner Side Effects"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...